Skip to main
SMLR
SMLR logo

Semler Scientific (SMLR) Stock Forecast & Price Target

Semler Scientific (SMLR) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Semler Scientific, Inc. is well-positioned for growth due to its proprietary vascular-testing product, QuantaFlo, which enhances the efficiency of healthcare providers in managing chronic diseases. The company’s strategic focus on healthcare technology solutions generates substantial cash flows, allowing it to invest in alternative assets like bitcoin, which adds another layer of financial resilience. Furthermore, the anticipated closing of a deal with Strive presents a promising opportunity, as the current SMLR discount to the implied deal value may indicate significant upside potential in the company's stock valuation.

Bears say

Semler Scientific faces a negative outlook primarily due to significant market skepticism regarding its valuation, exacerbated by the volatile nature of bitcoin, which impacts its treasury reserve strategy. The company's financial stability is further questioned as the implied value for Semler may diminish if Strive’s share price declines ahead of a key vote, potentially leading to renegotiation pressures. Additionally, the deal’s economics are closely linked to bitcoin's performance, which has been unfavorable, indicating that the market has not fully recognized or valued the implications of Strive’s strategy.

Semler Scientific (SMLR) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Semler Scientific and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Semler Scientific (SMLR) Forecast

Analysts have given Semler Scientific (SMLR) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Semler Scientific (SMLR) has a Strong Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $74.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $74.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Semler Scientific (SMLR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.